McLaren Teams Up With AbbVie Before Formula 1 United States GP At COTA

McLaren has announced a new partnership with pharmaceutical company AbbVie ahead of the Formula 1 United States Grand Prix at Circuit of the Americas (COTA). The collaboration marks AbbVie's entry into the Formula 1 sponsorship landscape, aligning with McLaren's growing commercial momentum in the sport. The deal is expected to bring AbbVie branding to the McLaren cars and team presence at the high-profile American race.